Simulations PlusFRA:SD3 67 PS Ratio is 4.59 as of Jul. 05, 2026, which is 66% below its 10-year median of 13.33. GuruFocus rates FRA:SD3 with a GF Score™ of 67/100 and a GF Value™ of €32.93 (Significantly Undervalued). The stock has 7 warning signs investors should review. Among 657 Healthcare Providers & Services companies, Simulations Plus ranks worse than 79.3% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Simulations Plus's share price is €15.80.
Simulations Plus's Revenue per Share for the trailing twelve months (TTM) ended in Feb. 2026 was €3.45. Hence, Simulations Plus's PS Ratio for today is 4.59.
The historical rank and industry rank for Simulations Plus's PS Ratio or its related term are showing as below:
FRA:SD3'
s PS Ratio Range Over the Past 10 Years
Min: 2.86 Med: 13.33 Max: 38.09
Current: 4.61
During the past 13 years, Simulations Plus's highest PS Ratio was 38.09. The lowest was 2.86. And the median was 13.33.
FRA:SD3's PS Ratio is ranked worse than 79.3% of 657
companies
in the Healthcare Providers & Services industry
Industry Median: 1.5
vs FRA:SD3: 4.61
Simulations Plus Inc revenue growth has slowed down over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of Simulations Plus was 3.10% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 14.90% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 12.80% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 13.70% per year.
During the past 13 years, Simulations Plus's highest 3-Year average Revenue per Share Growth Rate was 25.40% per year. The lowest was -28.30% per year. And the median was 10.75% per year.
Back to Basics: PS Ratio
Simulations Plus (FRA:SD3) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Simulations Plus PS Ratio Related Terms
Simulations Plus PS Ratio Historical Data
* Premium members only.
The historical data trend for Simulations Plus's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Simulations Plus's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Simulations Plus PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Simulations Plus's PS Ratio distribution charts can be found below:
* The bar in red indicates where Simulations Plus's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Simulations Plus's Share Price of today is €15.80. Simulations Plus's Revenue per Share for the trailing twelve months (TTM) ended in Feb. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €3.45.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Simulations Plus (FRA:SD3) has a PS Ratio of 4.59 as of Jul. 05, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Simulations Plus and its competitors. This is 66% below median its historical median of 13.33. Over the past decade, Simulations Plus' PS Ratio has ranged from 2.86 to 38.09. According to the industry distribution chart, Simulations Plus ranks #521 out of 657 companies in the Healthcare Providers & Services industry, placing it in the top 79.3%.
Is Simulations Plus' PS Ratio too high?
Simulations Plus' current PS Ratio of 4.59 is 66% below median its 10-year median of 13.33. Over the past 10 years, this metric has ranged from a low of 2.86 to a high of 38.09. The Healthcare Providers & Services industry median PS Ratio is 1.50. Simulations Plus' value of 4.59 is 206% above this industry median. Based on the distribution chart, Simulations Plus ranks #521 out of 657 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Simulations Plus has a GF Score™ of 67/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Simulations Plus' PS Ratio compare to TBRG and CARL?
According to the Healthcare Providers & Services industry distribution chart, Simulations Plus ranks #521 out of 657 companies for PS Ratio. This places Simulations Plus in the lower half of its industry. The industry median PS Ratio is 1.50. Simulations Plus' value of 4.59 is 206% above this benchmark. Historically, Simulations Plus' own PS Ratio has ranged from 2.86 to 38.09 over the past decade. While the company's 10-year median is 13.33 vs. the industry median of 1.50, Simulations Plus has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Healthcare Providers & Services company?
The median PS Ratio among Healthcare Providers & Services companies is 1.50, based on 657 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Simulations Plus's current PS Ratio of 4.59 is 206% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Simulations Plus and its competitors. For the Healthcare Providers & Services industry, the median PS Ratio is 1.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Simulations Plus's current PS Ratio is 4.59, which is 66% below median its own 10-year median of 13.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Simulations Plus stock overvalued right now?
Based on GuruFocus' analysis, Simulations Plus (FRA:SD3) is currently considered Significantly Undervalued. The stock's GF Value™ is €32.93, compared to a current price of €15.80 — trading 52% below its estimated fair value. The current PS Ratio is 4.59, which is 66% below median its 10-year median of 13.33 and 206% above the Healthcare Providers & Services industry median of 1.50. Simulations Plus' overall GF Score™ is 67/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Simulations Plus (FRA:SD3), the current PS Ratio is 4.59 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Simulations Plus (FRA:SD3) Overvalued in 2026?
Based on GuruFocus' analysis, Simulations Plus stock appears to be undervalued.
The current stock price of €15.80 is trading 52% below its estimated GF Value™ of €32.93.
GuruFocus considers Simulations Plus to be Significantly Undervalued.
Key valuation signals for FRA:SD3:
PS Ratio: 4.59 (66% below median its 10-year median of 13.33)
GF Value™: €32.93 vs. price of €15.80 (52% below fair value)
Industry Position: 206% above the Healthcare Providers & Services median (#521 of 657)
No single metric tells the full story. See the FRA:SD3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.
67GF Score
Get the complete analysis for FRA:SD3
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:SD3 has been successfully added to your 
